References

Allen, J.S., G. Dougan and R.A. Strugnell, 2000. Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium. FEMS Immunol. Med. Microbiol., 27: 275-281.
CrossRef  |  

Angelakopoulos, H. and E.L. Hohmann, 2000. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immunity, 68: 2135-2141.
CrossRef  |  PubMed  |  

Behr, M.A., M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, S. Rane and P.M. Small, 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 284: 1520-1523.
PubMed  |  Direct Link  |  

Bowe, F., D.J. Pickard, R.J. Anderson, P. Londono-Arcila and G. Dougan, 2003. Development of Attenuated Salmonella Strains that Express Heterologous Antigens. In: Vaccine Protocols, Robinson, A., M.J. Hudson and M.P. Cranage (Eds.). Humana Press, New York, ISBN-13: 9781588291400, pp: 83-100.

Brandt, L., M. Elhay and I. Rosenkrands, 2000. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun., 68: 791-795.
PubMed  |  Direct Link  |  

Brandt, L., T. Oettinger, A. Holm, A.B. Andersen and P. Andersen, 1996. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J. Immun., 157: 3527-3533.
Direct Link  |  

Challacombe, S.J., D. Rahman and D.T. O'Hagan, 1997. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine, 15: 169-175.
CrossRef  |  

Chen, F., J. Zhou, F.L. Luo, A.B. Mohammed and X.L. Zhang, 2007. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem. Biol. Res. Commun., 357: 743-748.
PubMed  |  Direct Link  |  

Colditz, G.A., T.F. Brewer, C.S. Berkey, E. Wilson, E. Burdick, H.V. Fineberg and F. Mosteller, 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc., 271: 698-702.
PubMed  |  

Fine, P.E., 2001. BCG: The challenge continues. Scand. J. Infect. Dis., 33: 243-245.
CrossRef  |  

Golub, J.E., B. Durovni, B.S. King, S.C. Cavalacante and A.G. Pacheco et al., 2008. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS, 22: 2527-2533.
CrossRef  |  

Hess, J., L. Grode, J. Hellwig, P. Conradt and I. Gentschev et al., 2000. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol. Med. Microbiol., 27: 283-289.
CrossRef  |  

Khan, S., S. Chatfield, R. Stratford, J. Bedwell and M. Bentley et al., 2007. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine, 25: 4175-4182.
CrossRef  |  

Kirkpatrick, B.D., R. McKenzie, J.P. O'Neill, C.J. Larsson and A.L. Bourgeois et al., 2006. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine, 24: 116-123.
CrossRef  |  

Kuo, C.J., H. Bell, C.L. Hsieh, C.P. Ptak and Y.F. Chang, 2012. Novel mycobacteria antigen 85 complex binding motif on fibronectin. J. Biol. Chem., 287: 1892-1902.
CrossRef  |  

Mollenkopf, H.J., D. Groine-Triebkorn, P. Andersen, J. Hess and S.H. Kaufmann, 2001. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine, 19: 4028-4035.
CrossRef  |  

Olsen, A.W., L.A. Van Pinxteren, L.M. Okkels, P.B. Rasmussen and P. Andersen, 2001. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect. Immunity, 69: 2773-2778.
CrossRef  |  

Pym, A.S., P. Brodin, L. Majlessi, R. Brosch and C. Demangel et al., 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med., 9: 533-539.
PubMed  |  Direct Link  |  

Ruedl, C., M. Fruhwirth, G. Wick and H. Wolf, 1994. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin. Diagn. Lab. Immunol., 1: 150-154.
Direct Link  |  

Sala, C. and R.C. Hartkoorn, 2011. Tuberculosis drugs: New candidates and how to find more. Future Microbiol., 6: 617-633.
CrossRef  |  

Sirard, J.C., F. Niedergang and J.P. Kraehenbuhl, 1999. Live attenuated Salmonella: A paradigm of mucosal vaccines. Immunol. Rev., 171: 5-26.
CrossRef  |  PubMed  |  

Tacket, C.O., M.B. Sztein, S.S. Wasserman, G. Losonsky and K.L. Kotloff et al., 2000. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers. Infect. Immunity, 68: 1196-1201.
CrossRef  |